Navigation Links
Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
Date:11/20/2013

DUBLIN, November 20, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/84xb3g/microarray_markets) has announced the addition of the "Microarray Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics.

Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices.

This report describes the specific segment of the microarray market aimed at the analysis of proteins and DNA. It examines various microarray platforms and the technologies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring.  Detailed tables and charts with sales forecasts and marketshare data are also included.


Companies Mentioned:

- Affymetrix
- Agilent Technologies, Inc
- AyoxxA
- Bio-Rad Laboratories
- BioCat GmbH
- CYBRDI
- Cancer Genetics, Inc
- Cepheid, Inc
- DiagnoSwiss SA
- Exiqon
- Fluidigm Corporation
- GE Healthcare
- Gyros AB
- Healthcare IT, Inc
- Illumina, Inc
- InDevR
- Luminex Corporation
- Myriad Genetics, Inc
- NextGen Sciences PLC
- One Lambda
- ProteoGenix
- QIAGEN
- R&D Systems
- RayBiotech
- Toray Industries, Inc
- Trans Genic, Inc
- US Biomax
- Veredus Laboratories Pte Ltd
- Zeus Scientific, Inc
- Zyagen


For more information visit http://www.researchandmarkets.com/research/84xb3g/microarray_markets

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck
2. Global Biochips and Microarrays 2013 Market Report
3. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
4. Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
5. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
6. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
7. BCC Research Publishes a New Report on Global Markets for Biochips
8. BCC Research Publishes a New Report On Global Markets for Rnai Technologies
9. Interventional Cardiology Devices - Emerging Markets 2009-2015
10. IDC MarketScape annovera la soluzione cloud-based di Veeva tra le principali soluzioni CRM dedicate alle scienze della vita
11. IDC MarketScape Named Cloud-based Veeva a Leader in Life Sciences CRM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):